Cargando…
Economic burden of antibiotic resistance in China: a national level estimate for inpatients
BACKGROUND: Antibiotic resistance (AR) threats public health in China. National-level estimation of economic burden of AR is lacking. We aimed to quantify the economic costs of AR in inpatients in China. METHODS: We performed a multicentre and retrospective cohort study including 15,990 patient epis...
Autores principales: | Zhen, Xuemei, Stålsby Lundborg, Cecilia, Sun, Xueshan, Zhu, Nina, Gu, Shuyan, Dong, Hengjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789653/ https://www.ncbi.nlm.nih.gov/pubmed/33407856 http://dx.doi.org/10.1186/s13756-020-00872-w |
Ejemplares similares
-
Correction to: Economic burden of antibiotic resistance in China: a national level estimate for inpatients
por: Zhen, Xuemei, et al.
Publicado: (2021) -
Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused by Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020) -
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
por: Zhen, Xuemei, et al.
Publicado: (2019) -
The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis
por: Zhen, Xuemei, et al.
Publicado: (2019) -
Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)